Method for the analysis of circulating antibodies

(19)

(11)

EP 2 141 497 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	23.07.2014 Bulletin 2014/30

(45)	Mention of the grant of the patent:
	26.03.2014 Bulletin 2014/13

(21)	Application number: 09163976.5

(22)	Date of filing: 29.06.2009

(51)

International Patent Classification (IPC):

G01N 33/558^(2006.01)

B01L 3/00^(2006.01)

(54)	Method for the analysis of circulating antibodies Verfahren zur Analyse von umlaufenden Antikörpern Procédé pour l'analyse d'anticorps circulants

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30)

Priority:

03.07.2008 SE 0801587
03.07.2008 US 78295 P

(43)	Date of publication of application:
	06.01.2010 Bulletin 2010/01

(73)	Proprietor: Johnson & Johnson Aktiebolag
	191 84 Sollentuna (SE)

(72)	Inventors:
	Mendel-Hartvig, Ib 756 55, Uppsala (SE) Pettersson, Christer 743 35, Storvreta (SE) Rundström, Gerd 752 41, Uppsala (SE)

(74)	Representative: Carlsson, Carl Fredrik Munk
	Bergenstråhle & Lindvall AB P.O. Box 17704 118 93 Stockholm 118 93 Stockholm (SE)

(56)

References cited: :

WO-A-03/103835
WO-A-2005/118139
US-A- 4 275 053
US-A- 5 773 222

WO-A-2004/029221
WO-A-2007/149043
US-A- 5 192 663

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).